
### [MONDO:0015981](http://purl.obolibrary.org/obo/MONDO_0015981)
**Label:** genetic gynecological tumor

**Subclasses:** [MONDO:0010804](http://purl.obolibrary.org/obo/MONDO_0010804) (BRCATA), [MONDO:0016249](http://purl.obolibrary.org/obo/MONDO_0016249) (hereditary site-specific ovarian cancer syndrome), [MONDO:0016248](http://purl.obolibrary.org/obo/MONDO_0016248) (familial ovarian cancer), [MONDO:0015442](http://purl.obolibrary.org/obo/MONDO_0015442) (hereditary breast and ovarian cancer syndrome), [MONDO:0013253](http://purl.obolibrary.org/obo/MONDO_0013253) (breast-ovarian cancer, familial, susceptibility to, 3), [MONDO:0011450](http://purl.obolibrary.org/obo/MONDO_0011450) (breast-ovarian cancer, familial, susceptibility to, 1), [MONDO:0013669](http://purl.obolibrary.org/obo/MONDO_0013669) (breast-ovarian cancer, familial, susceptibility to, 4), [MONDO:0016419](http://purl.obolibrary.org/obo/MONDO_0016419) (hereditary breast carcinoma), [MONDO:0011543](http://purl.obolibrary.org/obo/MONDO_0011543) (BRCA3), [MONDO:0012933](http://purl.obolibrary.org/obo/MONDO_0012933) (breast-ovarian cancer, familial, susceptibility to, 2), 

**Corr. equiv. classes:** [OMIM:613399](http://purl.obolibrary.org/obo/OMIM_613399), [Orphanet:213517](http://www.orpha.net/ORDO/Orphanet_213517), [Orphanet:145](http://www.orpha.net/ORDO/Orphanet_145), [OMIM:600048](http://purl.obolibrary.org/obo/OMIM_600048), [OMIM:612555](http://purl.obolibrary.org/obo/OMIM_612555), [OMIM:114480](http://purl.obolibrary.org/obo/OMIM_114480), [OMIM:614291](http://purl.obolibrary.org/obo/OMIM_614291), [OMIM:605365](http://purl.obolibrary.org/obo/OMIM_605365), [Orphanet:227535](http://www.orpha.net/ORDO/Orphanet_227535), [OMIM:604370](http://purl.obolibrary.org/obo/OMIM_604370), [Orphanet:213524](http://www.orpha.net/ORDO/Orphanet_213524), 

**Class expressions from DL-Learner:**

- [HP:0000006](http://purl.obolibrary.org/obo/HP_0000006) (Autosomal dominant inheritance) and [HP:0003002](http://purl.obolibrary.org/obo/HP_0003002) (Breast carcinoma) 39.75%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0003002](http://purl.obolibrary.org/obo/HP_0003002) (Breast carcinoma) 39.75%
- [HP:0000006](http://purl.obolibrary.org/obo/HP_0000006) (Autosomal dominant inheritance) and [HP:0100013](http://purl.obolibrary.org/obo/HP_0100013) (Neoplasm of the breast) 38.64%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0100013](http://purl.obolibrary.org/obo/HP_0100013) (Neoplasm of the breast) 38.64%
- [HP:0003002](http://purl.obolibrary.org/obo/HP_0003002) (Breast carcinoma) and (not ([HP:0000160](http://purl.obolibrary.org/obo/HP_0000160) (Narrow mouth))) 37.79%
- [HP:0003002](http://purl.obolibrary.org/obo/HP_0003002) (Breast carcinoma) and (not ([HP:0000034](http://purl.obolibrary.org/obo/HP_0000034) (Hydrocele testis))) 37.79%
- [HP:0003002](http://purl.obolibrary.org/obo/HP_0003002) (Breast carcinoma) 36.75%
- [HP:0100013](http://purl.obolibrary.org/obo/HP_0100013) (Neoplasm of the breast) 33.80%
- [HP:0031093](http://purl.obolibrary.org/obo/HP_0031093) (Abnormal breast morphology) 23.63%
- [HP:0000769](http://purl.obolibrary.org/obo/HP_0000769) (Abnormality of the breast) 23.48%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) 21.57%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) 21.41%
- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 19.20%
- Thing 19.20%
- [HP:0000001](http://purl.obolibrary.org/obo/HP_0000001) (All) 19.20%


